Trimedyne
HOME

ABOUT US

PRODUCTS

EDUCATION & TRAINING

INVESTOR RELATIONS

EVENTS

 

Company History

Management Team

Press Releases

Contact Us

Careers



Laser Spine Therapy
Provider List


 


Company History

     Trimedyne, Inc. is a manufacturer of lasers and disposable fiber optic delivery devices for use in a variety of surgical applications including, urology, orthopedics, ENT surgery, gynecology, GI surgery, and general surgery. Trimedyne's lasers and proprietary delivery systems are designed to reduce the bleeding and trauma of conventional surgery, reduce or eliminate hospital bed stays and shorten recuperation time.

     Cardiodyne, a 90% subsidiary of Trimedyne is developing a heart revascularization laser system for cardiovascular surgeons and cardiologists to treat coronary artery disease, the largest single killer among medical conditions and diseases.

     Trimedyne is a publicly traded company, listed on the NASDAQ National Market System under the symbol "TMED."

 

Trimedyne Highlights


1980

Company Founded

1982

Acquired Fiber Optics Company

1983

IPO ($1.20 per share)

1987  

First laser approved for sale by FDA for treating blockages in peripheral (below the waist) arteries

1992  

Holmium laser cleared for sale by FDA for use in arthroscopy

1994

Holmium laser cleared for sale by FDA for use in urology

1995

Launched 80 watt Holmium laser - OmniPulse MAX™

1996

First laser device cleared for sale by FDA for treating enlarged prostates

1997

OmniTip
switchable tips cleared for sale by FDA

1998

Reusable bare fiber cleared for sale by FDA

1999

Laser Needle cleared by FDA for use in decompression of lumbar ( herniated ) spinal discs

2000

Joint marketing agreement with Surgical Innovations
& Services ( SIS )

 
Top of Page


Home | About Us | Products | Education & Training | Investor Relations | Events
What's New | Careers | DoublePulse | Site Map | Contact Us

© Copyright 2000 - 2003 Trimedyne, Inc.  All rights reserved.